Market Currents
Merck (MRK) receives FDA approval to revise the biologics labeling on both the...
-
Thursday, December 13, 2012, 7:18 PM ETMerck (MRK) receives FDA approval to revise the biologics labeling on both the refrigerator-stable and frozen formulations of it's Chicken pox vaccine Varivax Details of the revised labeling aren't currently available.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
